Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix.
Open Access
- 1 August 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 17 (8) , 2027-2034
- https://doi.org/10.1093/humrep/17.8.2027
Abstract
To establish long-term safety, follow-up data on pregnancy, birth and neonatal outcome were collected during clinical development trials with ganirelix (Orgalutran) in women undergoing controlled ovarian stimulation for conventional IVF or ICSI.Keywords
This publication has 0 references indexed in Scilit: